Setting; 1) a community setting in New Zealand; 2) two gynaecology outpatient INTRODUCTION better measured using validated, condition-specific instruments such as those 103 developed by the International Consultation on Incontinence Questionnaire (ICIQ) 104 group 6 , and that there remains a need for a brief symptom index which encapsulates 105 the presence and extent of key prolapse symptoms. We report here on a scale 106 which fulfils this need. 
115
Our intention was to supplement the POP-SS with a number of existing validated 116 scales aimed specifically at urinary (ICIQ-UI SF 7 ), bowel (ICIQ-BS 6 ) and sexual 117 symptoms (PISQ-12 8 ), so that these functions could be assessed independently.
119
We administered the POP-SS to women in a number of research studies in order to 120 generate data on its acceptability and performance. This article presents the findings 
127
The POP-SS consists of seven items, each with a 5-point Likert response set 128 (0=never, 1=occasionally, 2=sometimes, 3=most of the time, 4=all of the time) (Table   129 1). The question format and response set were modelled on those used by the ICIQ 130 something coming down in the vagina). A total score (range 0 to 28) is calculated by 137 summing the seven individual symptom responses to derive the POP-SS score. In 138 addition, women indicate which one of the seven symptoms causes them most 139 bother (Table 1) .
141
At an early stage the POP-SS was assessed in qualitative interviews with 10 women 142 (mean age 49 years) during which they completed the seven questions as part of a 143 larger questionnaire. Women, who had either stage I (n=5) or II (n=5) prolapse, were 144 purposively selected to represent the range of prolapse types (4 rectocele, 3 145 cystocele, 2 rectocele+cystocele, 1 uterine prolapse). The "think aloud" method 12 146 was used to encourage women to make explicit their understanding of the questions 147 and rationale for responses chosen. Women were also asked to comment on the 148 comprehensiveness and acceptability of the questionnaire. This approach provided 149 evidence of content validity and acceptability, since women could understand the 150 questions, and found them acceptable and relevant to the symptoms that troubled 151 them in relation to their prolapse 13 .
153
The POP-SS has to date been used in three studies 14.15,16 , undertaken by the same Study 1: PROlapse and incontinence: LONG-term research (ProLong) 14 
159
In New Zealand in 2005, 435 women were followed up 12 years after giving birth, at 160 which time they had responded to a survey investigating postnatal urinary and faecal 161 incontinence 17 . All women completed the POP-SS, and a sub-group of 166 women 162 agreed to have objective prolapse assessment using the Pelvic Organ Prolapse -
163
Quantification system (POP-Q) 18 . Women were not known to be symptomatic of Cronbach's alpha was between 0.7 and 0.9 21 . It is undesirable for alpha to be too 216 high as this suggests redundancy in the items of the scale.
218
In assessing trait validity, initially mean and median scores for the three study groups 219 were tabulated. Non-parametric one-way analysis of variance (Kruskal-Wallis) was 220 used to test for a significant difference between groups. Parametric analysis of 221 variance, with post-hoc t-tests of differences between group means with Bonferroni 222 correction, was also performed.
224
In terms of sensitivity to change, the Wilcoxon paired test was used to test for 225 statistically significant differences between pre-and post-intervention POP-SS scores 226 within studies. Differences between studies in pre-to post-intervention change in 227 score were tested using the Mann-Whitney U test.
229
Analysis was undertaken using SPSS software and a 5% level of significance was 230 used throughout. In both the POPPY and IMPRESS studies a significant decrease in score after the 272 interventions was detected ( Table 4 ). The average decrease in score was shown to 273 be significantly greater in the IMPRESS women than in the POPPY women (z = - 
342
Generally we avoided in our scale such questions, however these symptoms, more 343 than others, are linked frequently with prolapse and were regarded to be worth 
366
It has been shown that the POP-SS is a measure with good internal consistency; it is 367 valid as a measure of prolapse symptoms as scores differed predictably between 368 groups of women known to differ in their prolapse symptoms; finally, it is sensitive to 369 the change brought about by treatment for prolapse, specifically surgical repair and 370 PFMT.
372
The POP-SS is a brief questionnaire which is acceptable to women and lends itself to 
